Topamax Birth Defect Study Leads to Increased FDA Warnings Says O’Hanlon, McCollom and Demerath

Topamax Birth Defect Study Leads to Increased FDA Warnings Says O’Hanlon, McCollom and Demerath The attorneys at O’Hanlon, McCollom and Demerath announce free legal consultations to mothers who took Topamax during pregnancy and gave birth to children with birth defects such as cleft lip or cleft palate. The FDA recently strengthened their warning for Topamax stating that expecting mothers taking the drug are 20 times more likely to suffer a birth defect. Austin, TX (PRWEB) May 10, 2011 O’Hanlon, McCollom and Demerath reports: according to a 2008 scientific study published in Neurology, ta
Contributor
PR Web
PR Web
Lanham, Maryland
Law Marketing
1.800.345.5572
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Download

Related Documents in PR Web
MCLE Sales

Categories